The management of dermal filler complications.
Injectable fillers have gained widespread acceptance among the public and provide a nonsurgical means of rejuvenating the face. As the demand for fillers increases, facial plastic surgeons must become not only expert injectors but also experts in managing the complications of fillers. Little scientific data exists regarding the incidence of complications, and more adverse effects may be seen with longer-term follow-up of patients. The purpose of this article is to review the most commonly encountered complications and management thereof.
Winslow
Catherine P
CP
Indiana University School of Medicine, Indianapolis, Indiana, USA. drwinslow@indyface.com
D001672:Biocompatible Materials / Q000008:administration & dosage* / Q000009:adverse effects*; D002921:Cicatrix / Q000209:etiology / Q000628:therapy; D003288:Contusions / Q000209:etiology / Q000628:therapy; D003357:Cosmetic Techniques / Q000009:adverse effects*; D004487:Edema / Q000209:etiology / Q000628:therapy; D004890:Erythema / Q000209:etiology / Q000628:therapy; D005145:Face; D005157:Facial Pain / Q000209:etiology / Q000628:therapy; D015745:Granuloma, Foreign-Body / Q000209:etiology / Q000628:therapy; D006633:Histamine Antagonists / Q000627:therapeutic use; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy / Q000209:etiology; D007053:Ice; D007249:Inflammation / Q000209:etiology / Q000628:therapy; D007271:Injections, Intradermal / Q000009:adverse effects*; D009336:Necrosis / Q000188:drug therapy / Q000209:etiology; D010859:Pigmentation Disorders / Q000209:etiology / Q000628:therapy; D012060:Rejuvenation; D015595:Skin Aging; D014665:Vasodilator Agents / Q000627:therapeutic use
D001672:Biocompatible Materials; D006633:Histamine Antagonists; D007053:Ice; D014665:Vasodilator Agents